Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary percutaneous coronary intervention: pooled patient-level analysis from the HORIZONS-AMI and EUROMAX trials.

Stone, Gregg W; Mehran, Roxana; Goldstein, Patrick; Witzenbichler, Bernhard; Van't Hof, Arnoud; Guagliumi, Giulio; Hamm, Christian W; Généreux, Philippe; Clemmensen, Peter; Pocock, Stuart J; +4 more... Gersh, Bernard J; Bernstein, Debra; Deliargyris, Efthymios N; Steg, Philippe Gabriel; (2014) Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary percutaneous coronary intervention: pooled patient-level analysis from the HORIZONS-AMI and EUROMAX trials. Journal of the American College of Cardiology, 65 (1). pp. 27-38. ISSN 0735-1097 DOI: https://doi.org/10.1016/j.jacc.2014.10.029

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/j.jacc.2014.10.029

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar